6505--Notice of Intent to Sole Source F18 Piflufolastat (PYLARIFY) Doses for PET/CT for Overton Brooks VA Medical Center, Shreveport, LA
Closed Special Notice Posted
- Solicitation number
- 36C25625Q0554
- Agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VISN 16) has issued a Special Notice announcing its intent to award a sole source Federal Supply Schedule Delivery Order to Progenics Pharmaceuticals, Inc. for F-18 Pylarify (piflufolastat) doses. The notice pertains to a procurement for the Overton Brooks VA Medical Center in Shreveport, Louisiana, seeking 200 doses of a radioactive diagnostic agent used for positron emission tomography (PET) imaging of prostate cancer patients. The procurement will be conducted under VA NAC Federal Supply Schedule 36F79719D0170, with Progenics Pharmaceuticals being the sole manufacturer of this specialized product. The justification for the sole source action is based on Federal Acquisition Regulation (FAR) 8.405-6(a)(1)(B), which allows for procurement from the only source capable of providing unique or highly specialized supplies at the required quality level.
The primary objective of this Special Notice is to inform potential contractors about the VA's intention to negotiate a delivery order with Progenics Pharmaceuticals, while providing an opportunity for other parties to demonstrate their capability to meet the contract requirements. Interested contractors must submit detailed capability statements with customer references by March 3, 2025, at 6:00 PM Eastern Time via email to ross.futch@va.gov. The period of performance for this contract will run from April 1, 2025, through March 31, 2026, with all deliveries to be made to the Nuclear Medicine Service at the Overton Brooks VA Medical Center. Eligible contractors must be able to provide F-18 Pylarify with proper licensing, regulatory compliance, and the ability to meet specific delivery and quality control requirements. The NAICS code for this procurement is 325412 (Pharmaceutical Preparation Manufacturing), with a size standard of 1,300 employees. While the notice is not a competitive solicitation, the VA will evaluate any submitted capability statements, with the final determination of sole sourcing remaining at the government's discretion.
Notice text
This is a notice of the Government s intent to award a sole source, Federal Supply Schedule Delivery Order to Progenics Pharmaceuticals, Inc located at 331 Treble Cove Road, N. Billerica, MA 01862 . The justification for the sole source action is the authority at FAR 8.405-6(a)(1)(B), Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. Network Contracting Office 16 in support of The Veterans Integrated Service Network 16 (VISN 16), Overton Brooks VA Medical Center intends to negotiate a sole source Delivery Order with Progenics Pharmaceuticals Inc. (doing business as Lantheus Medical Imaging, Inc.) under VA NAC Federal Supply Schedule 36F79719D0170 for the supply and delivery of F-18 Pylarify (piflufolastat or 18F-DCFPyl), Unit of Issue: EA, Quantity: 200. PYLARIFY is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: 1) with suspected metastasis who are candidates for initial definitive therapy, 2) with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. The National Drug Code for F-18 Pylarify is 71258-0022-01. Progenics Pharmaceuticals Inc. (SAM UEI: YLYKVRPCTCR3) is the manufacturer of F-18 Pylarify which utilizes down-chain distribution partners for delivery to its customers. F-18 is only available for purchase through Progenics Pharmaceuticals Inc. All deliveries will be made to the Overton Brooks VA Medical Center, Nuclear Medicine Service (115) located at 510 East Stoner Avenue, Shreveport LA 71101. A single delivery order will be awarded. The period of performance of the requirement will be from April 1, 2025 through March 31, 2026. The applicable NAICS code is 325412, Pharmaceutical Preparation Manufacturing (SBA Size Standard: 1300 employees). This Notice of Intent is not a request for competitive quotes. No solicitation documents are available and telephonic requests will not be taken. However, if a party believes it can meet the requirements to provide F-18 Pylarify it must furnish information about its products and services, as well as references from other customers who are using these products and services to the Contracting Officer by 6:00 PM Eastern Time on Monday, March 3, 2025. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to perform the described work. Responses received will be evaluated, however; a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. After the closing date and time of this notice, if no other substantiated sources are identified, the Contracting Officer will proceed with the sole source negotiation with Progenics Pharmaceuticals Inc. (SAM UEI: YLYKVRPCTCR3). Capability statements shall be submitted by email only as a MS Word or Adobe PDF attachment to Ross Futch at ross.futch@va.gov. TELEPHONIC INQUIRIES WILL NOT BE ACCEPTED.
Files
| File | Type | Posted |
|---|---|---|
| PWS Pylarify.docx | DOCX document | |
| 36C25625Q0554.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS | Veterans Integrated Service Network 2 | No set-aside | |
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside | |
| 6635--Dosimetry and Exposure Monitoring Services - VISN 1 BPA | Veterans Integrated Service Network 1 | No set-aside | |
| J065--Fort Harrison GE Precision Radiology Preventive Maintenance | Veterans Integrated Service Network 19 | No set-aside | |
| J066 - PM Illumina Equipment | Department of Veterans Affairs | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity